BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17855570)

  • 1. Proficiency analysis of drug susceptibility testing by national-level tuberculosis reference laboratories from 1995 to 2003.
    Bai GH; Kim SJ; Chang CL;
    J Clin Microbiol; 2007 Nov; 45(11):3626-30. PubMed ID: 17855570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
    Laszlo A; Rahman M; Espinal M; Raviglione M;
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):748-56. PubMed ID: 12234129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-tuberculosis drug resistance survey in Japan, 2002: external quality assessment of results].
    Tuberculosis Research Committee
    Kekkaku; 2007 Mar; 82(3):155-64. PubMed ID: 17444118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].
    Mitarai S;
    Kekkaku; 2005 Apr; 80(4):349-58. PubMed ID: 15991600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of anti-tuberculosis drug resistance: results of the 1998/1999 proficiency testing in Italy. SMIRA (Italian Multicentre Study on Antituberculosis Drug Resistance) Study Group.
    Migliori GB; Ambrosetti M; Fattorini L; Penati V; Vaccarino P; Besozzi G; Ortona L; Saltini C; Orefici G; Moro ML; Lona E; Cassone A
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):940-6. PubMed ID: 11055761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007.
    Shulgina MV; Malakhov VN; Hoffner SE; Haile M; Wright A
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1294-300. PubMed ID: 19793436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External quality control of Mycobacterium tuberculosis drug susceptibility testing: results of two rounds in endemic countries.
    Fattorini L; Iona E; Cirillo D; Migliori GB; Orefici G; Aziz M; Wright A; Tafaj S; Baig B; Mulliqi G; Maungate S; Cuna Z; Al-Busaidy S; Al-Suwaidi Z; Ceyhan I
    Int J Tuberc Lung Dis; 2008 Feb; 12(2):214-7. PubMed ID: 18230256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [External quality assessment of drug susceptibility testing for Mycobacterium tuberculosis].
    Mitarai S; ;
    Kekkaku; 2006 Aug; 81(8):501-9. PubMed ID: 16972653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis on quality control of drug susceptibility testing in the surveillance of drug resistance in tuberculosis in Henan].
    Xu J; Peng Y; Wang G
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):724-6. PubMed ID: 11480073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan.
    Jou R; Chiang CY; Yu CY; Wu MH
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1142-7. PubMed ID: 19723405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan: comparison of results in the local facilities and in the reference laboratory, in 1997].
    Hirano K; Wada M; Abe C; Aoyagi T
    Kekkaku; 2001 Jun; 76(6):461-71. PubMed ID: 11494526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs].
    Sayğan MB; Ocak F; Cesur S; Tarhan G; Ceyhan I; Gümüişlü F; Beker G; Güner U; Coşkun E
    Mikrobiyol Bul; 2007 Jul; 41(3):403-9. PubMed ID: 17933251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)--report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
    Drobniewski F; Rüsch-Gerdes S; Hoffner S;
    Clin Microbiol Infect; 2007 Dec; 13(12):1144-56. PubMed ID: 17727670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
    Kobayashi I; Abe C; Mitarai S
    Kekkaku; 2006 Feb; 81(2):57-62. PubMed ID: 16529006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method.
    van Klingeren B; Dessens-Kroon M; van der Laan T; Kremer K; van Soolingen D
    J Clin Microbiol; 2007 Aug; 45(8):2662-8. PubMed ID: 17537932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre evaluation of an automated BACTEC 960 system for susceptibility testing of Mycobacterium tuberculosis.
    Giampaglia CM; Martins MC; Vieira GB; Vinhas SA; Telles MA; Palaci M; Marsico AG; Hadad DJ; Mello FC; Fonseca Lde S; Kritski A
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):986-91. PubMed ID: 17705976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel kit for use with the BacT/ALERT 3D system for drug susceptibility testing of Mycobacterium tuberculosis.
    Werngren J; Klintz L; Hoffner SE
    J Clin Microbiol; 2006 Jun; 44(6):2130-2. PubMed ID: 16757609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [EVALUATION STANDARD OF EXTERNAL QUALITY ASSESSMENT PROGRAMME FOR DRUG SUSCEPTIBILITY TESTING OF MYCOBACTERIUM TUBERCULOSIS IN JAPANESE LABORATORIES: PROFICIENCY TESTING IN 2004-2010].
    Kekkaku; 2015 Apr; 90(4):481-90. PubMed ID: 26489152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.
    Hoffner S; Angeby K; Sturegård E; Jönsson B; Johansson A; Sellin M; Werngren J
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1486-90. PubMed ID: 24125455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.